Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

FAM134B, the Selective Autophagy Receptor for Endoplasmic Reticulum Turnover, Inhibits Replication of Ebola Virus Strains Makona and Mayinga.

Chiramel AI, Dougherty JD, Nair V, Robertson SJ, Best SM.

J Infect Dis. 2016 Oct 15;214(suppl 3):S319-S325. Epub 2016 Aug 10.

2.

Regulation of endoplasmic reticulum turnover by selective autophagy.

Khaminets A, Heinrich T, Mari M, Grumati P, Huebner AK, Akutsu M, Liebmann L, Stolz A, Nietzsche S, Koch N, Mauthe M, Katona I, Qualmann B, Weis J, Reggiori F, Kurth I, Hübner CA, Dikic I.

Nature. 2015 Jun 18;522(7556):354-8. doi: 10.1038/nature14498. Epub 2015 Jun 3.

PMID:
26040720
3.

Dengue and Zika viruses subvert reticulophagy by NS2B3-mediated cleavage of FAM134B.

Lennemann NJ, Coyne CB.

Autophagy. 2017 Feb;13(2):322-332. doi: 10.1080/15548627.2016.1265192. Epub 2017 Jan 19.

4.

Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.

Luczkowiak J, Arribas JR, Gómez S, Jiménez-Yuste V, de la Calle F, Viejo A, Delgado R.

Virus Res. 2016 Feb 2;213:224-229. doi: 10.1016/j.virusres.2015.12.019. Epub 2015 Dec 29.

PMID:
26739425
5.

Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Schweneker M, Laimbacher AS, Zimmer G, Wagner S, Schraner EM, Wolferstätter M, Klingenberg M, Dirmeier U, Steigerwald R, Lauterbach H, Hochrein H, Chaplin P, Suter M, Hausmann J.

J Virol. 2017 May 12;91(11). pii: e00343-17. doi: 10.1128/JVI.00343-17. Print 2017 Jun 1.

6.

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

Chiramel AI, Banadyga L, Dougherty JD, Falzarano D, Martellaro C, Brees D, Taylor RT, Ebihara H, Best SM.

J Infect Dis. 2016 Oct 15;214(suppl 3):S355-S359. Epub 2016 Aug 10.

7.

Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy.

Grumati P, Morozzi G, Hölper S, Mari M, Harwardt MI, Yan R, Müller S, Reggiori F, Heilemann M, Dikic I.

Elife. 2017 Jun 15;6. pii: e25555. doi: 10.7554/eLife.25555.

8.

Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.

Okumura A, Rasmussen AL, Halfmann P, Feldmann F, Yoshimura A, Feldmann H, Kawaoka Y, Harty RN, Katze MG.

J Virol. 2015 Oct;89(20):10399-406. doi: 10.1128/JVI.01736-15. Epub 2015 Aug 5.

9.

Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease.

Bird BH, Spengler JR, Chakrabarti AK, Khristova ML, Sealy TK, Coleman-McCray JD, Martin BE, Dodd KA, Goldsmith CS, Sanders J, Zaki SR, Nichol ST, Spiropoulou CF.

J Infect Dis. 2016 Mar 1;213(5):703-11. doi: 10.1093/infdis/jiv538. Epub 2015 Nov 17.

10.

Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.

Becquart P, Mahlakõiv T, Nkoghe D, Leroy EM.

PLoS One. 2014 Jun 10;9(6):e96360. doi: 10.1371/journal.pone.0096360. eCollection 2014.

11.

Cathepsin B & L are not required for ebola virus replication.

Marzi A, Reinheckel T, Feldmann H.

PLoS Negl Trop Dis. 2012;6(12):e1923. doi: 10.1371/journal.pntd.0001923. Epub 2012 Dec 6.

12.

Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo.

Herbert AS, Davidson C, Kuehne AI, Bakken R, Braigen SZ, Gunn KE, Whelan SP, Brummelkamp TR, Twenhafel NA, Chandran K, Walkley SU, Dye JM.

MBio. 2015 May 26;6(3):e00565-15. doi: 10.1128/mBio.00565-15.

14.

ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.

Han Z, Madara JJ, Liu Y, Liu W, Ruthel G, Freedman BD, Harty RN.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S138-45. doi: 10.1093/infdis/jiu838. Epub 2015 Mar 18.

15.

Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.

Dietzel E, Schudt G, Krähling V, Matrosovich M, Becker S.

J Virol. 2017 Jan 3;91(2). pii: e01913-16. doi: 10.1128/JVI.01913-16. Print 2017 Jan 15.

16.

Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.

Liang J, Sagum CA, Bedford MT, Sidhu SS, Sudol M, Han Z, Harty RN.

PLoS Pathog. 2017 Jan 11;13(1):e1006132. doi: 10.1371/journal.ppat.1006132. eCollection 2017 Jan. Erratum in: PLoS Pathog. 2017 Jul 19;13(7):e1006519.

17.

The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication.

Hill-Batorski L, Halfmann P, Neumann G, Kawaoka Y.

J Virol. 2013 Dec;87(24):13795-802. doi: 10.1128/JVI.02422-13. Epub 2013 Oct 9.

18.

Regulation of Ebola virus VP40 matrix protein by SUMO.

Baz-Martínez M, El Motiam A, Ruibal P, Condezo GN, de la Cruz-Herrera CF, Lang V, Collado M, San Martín C, Rodríguez MS, Muñoz-Fontela C, Rivas C.

Sci Rep. 2016 Nov 16;6:37258. doi: 10.1038/srep37258.

19.

Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum.

Bhattacharyya S, Hope TJ.

Virol J. 2011 Jan 12;8:11. doi: 10.1186/1743-422X-8-11.

20.

Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S941-6. doi: 10.1093/infdis/jir321.

PMID:
21987773

Supplemental Content

Support Center